DJIA 18,111.94 -51.05 -0.28%
NASDAQ 5,106.63 0.03 0.00%
S&P 500 2,120.44 -3.04 -0.14%
market minute promo

Gilead Sciences (NASDAQ: GILD)

112.46 0.00 (0.00%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

GILD $112.06 -0.36%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $112.01
Previous Close $112.46
Daily Range $111.82 - $112.99
52-Week Range $78.50 - $116.83
Market Cap $165.3B
P/E Ratio 12.81
Dividend (Yield) $1.72 (1.5%)
Ex-Dividend Date
Dividend Pay Date
06/12/15
06/29/15
Volume 383,975
Average Daily Volume 11,638,571
Current FY EPS $11.04

Sector

Healthcare

Industry

Drug Makers

Gilead Sciences (GILD) Description

Gilead Sciences created and sells the world’s top-selling HIV medications, Truvada and Atripla, and commands about 75% of the U.S. treatment market and more than 50% worldwide. Website: http://www.gilead.com/

News & Commentary

Undervalued Stocks in Biotech Worth Buying

Even though the term "bubble" is being tossed around with regard to biotech stocks, there are still three undervalued stocks in the sector worth buying.

Short Sellers Get Even More Ambitious Against Biotech Leaders

My Stock Watch List For June 2015

Merck/J&J Get CHMP Backing for Simponi's Expanded Use - Analyst Blog

Merck/J&J Get CHMP Backing for Simponi's Expanded Use - Analyst Blog

Alnylam (ALNY) Begins Phase I Study on Liver Disease Drug - Analyst Blog

The No. 1 Stock In The World: Why I Chose Disney (And Other Alternatives)

Health Care Sector Update for 05/27/2015: GBIM,GILD,GBSN,NURO

Should Dividend Growth Investors Go For Gilead?

Pharmacyclics' Imbruvica Gets CHMP's Nod for Full Approval - Analyst Blog

Pharmacyclics' Imbruvica Gets CHMP's Nod for Full Approval - Analyst Blog

See More GILD News...

GILD's Top Competitors

GILD $112.46 (0.00%)
Current stock: GILD
AMGN $156.92 (-2.19%)
Current stock: AMGN
CELG $114.77 (-1.08%)
Current stock: CELG
$0.00 (0.00%)
Current stock: